A cardiologist stuck on an unusual arrhythmia case doesn't call a colleague on VuMedi anymore — the platform's AI tool pulls up the exact clip of a specialist explaining that pattern, drawn from a library spanning more than 21 medical specialties. VuMedi, the Oakland-based peer-to-peer physician learning company founded in 2008, announced on November 10, 2026 that it has closed a $104 million Series B led by Oak HC/FT. The company did not disclose a valuation or how much it had raised previously.
The round is a growth investment, not an early bet. VuMedi says it will use the money to push its AI matching tool into more specialties and keep adding to a video library that already spans dozens of clinical areas.
A Video Library Doctors Actually Finish Watching
VuMedi's core product is simple: clinical videos and podcasts recorded by specialist physicians for other physicians, covering everything from rare surgical techniques to new device workflows. Doctors use it the way they used to use a trusted colleague down the hall — to get unstuck on a specific case fast.
The AI layer the company is now scaling connects a clinician's exact question to the relevant few minutes of expert video, rather than forcing a search through a full-length lecture. More than 150,000 NPI-verified clinicians have used that tool since launch, generating over 1 million AI interactions.
The engagement data is what likely drew Oak HC/FT's check. Physicians logged 56 million minutes of learning on VuMedi in the past 12 months, with active users averaging more than 52 minutes a month on the platform. VuMedi says clinicians who use its AI tool watch 122% more video than those who don't, and the library grew by 20,000 new videos over the same stretch — a pace that suggests both rising physician demand and an aggressive content pipeline.
A Crowded Field, Won on Format
VuMedi competes for physician attention with Medscape, Doximity and UpToDate, all of which have bolted AI summarization or search onto older, text-heavy reference products. VuMedi's bet is that video, not text, is what clinicians retain under time pressure, and that an AI matcher trained on a proprietary video library is harder to clone than a chatbot layered over a database.
Business Wire reported the round without detailing how funds will split between AI development, content production and sales, or whether VuMedi plans new specialty verticals or international markets.
Oak HC/FT typically backs growth-stage healthcare and fintech companies rather than seed-stage bets, and a $104 million check size signals it sees VuMedi closer to scale-up than experiment. The firm's involvement also puts VuMedi in the company of other health-tech platforms chasing physician engagement as a wedge into broader clinical workflows, from continuing-education credit to point-of-care decision support.
What to watch next: whether VuMedi converts its AI engagement lift into partnerships with hospital systems or medical societies, which would diversify revenue beyond ad-hoc video views, and whether the 122% engagement gap holds as the clinician base grows past 150,000 and the platform pushes into specialties where video content is thinner today.